Are current drug development programmes realising the full potential of new agents? Tyrosine kinase inhibitors

Detalles Bibliográficos
Autores principales: Gutteridge, Eleanor, Robertson, John FR
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797704/
https://www.ncbi.nlm.nih.gov/pubmed/20030876
http://dx.doi.org/10.1186/bcr2443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797704/
https://www.ncbi.nlm.nih.gov/pubmed/20030876
http://dx.doi.org/10.1186/bcr2443

Ejemplares similares